MaxHeal

Formulation and Development

  1. Home
  2. »
  3. Formulation and Development

Formulation & Development

Our Formulation & Development efforts are a driving force in our vision of becoming a leading pharmaceuticals company in India and internationally. Our Formulation & Development laboratory is accredited by the Department of Scientific and Industrial Research Technology, Our formulation and development solutions allow us to take an Active Pharmaceutical Ingredient (API) and create a stable, effective drug delivery platform.

The distinct features of our efforts include focusing in areas of core competence and a constant interest in exploring new and emerging technologies.

Development Process

MAXHEAL offers formulation development services to help clients determine optimal dosage levels of therapeutic formulations. MAXHEAL has a strong R&D department equipped with modern facilities to deliver the services those include pre – formulation, formulation development, method development, method validation, and analytical development and stability studies. Our formulation development solutions focus on generic formulations fulfilling regulatory requirements of target markets to achieve quality attributes and performance metrics set by clients. We provide end to end solutions from pre-formulation to manufacturing.

Developmental Expertise

An experienced team of scientists use their expertise in Formulation and Analytical development to leverage the rapid advancements in science to create new solutions, bringing us closer to better, more advanced and effective drug delivery systems.

Scale up

Using quality-by-design (Qbd) techniques, identifying critical process parameters (CPPs) and understanding the right process control strategies has enabled our technical team of engineers and scientist to successfully scale up to production.

Continual Innovation

Our focus is always towards exploring new scientific technologies and approaches, and determine their applicability, while keeping abreast of competitive products and technology advances.

Scale up

Using quality-by-design (Qbd) techniques, identifying critical process parameters (CPPs) and understanding the right process control strategies has enabled our technical team of engineers and scientist to successfully scale up to production.

Regulatory Proficiency

Our Regulatory team has deep capabilities required to complement our development team and deliver strategies to support the successful commercialization of product portfolios.

R&D Capabilities

MAXHEAL Pharmaceuticals takes pride in its robust Research & Development (R&D) capabilities, which are dedicated to driving innovation in the pharmaceutical industry. Below is an overview of their key R&D focus areas and capabilities:

Product Development & Innovation

Expertise in developing both generic and innovative pharmaceutical formulations across a wide range of therapeutic segments.

Clinical Trials & Testing

MAXHEAL conducts comprehensive clinical trials to ensure the safety, efficacy, and regulatory compliance of its pharmaceutical products.

Global Regulatory Expertise

MAXHEAL's R&D teams work closely with regulatory bodies such as the US FDA, EMA, and Indian regulatory authorities to meet global standards.

Sustainability and Green Chemistry

MAXHEAL’s R&D is also dedicated to sustainability, focusing on greener processes, energy-efficient technologies, and eco-friendly packaging.